INCREASED RISK OF CARDIAC ISCHEMIA AND ARTERIAL THROMBOEMBOLIC EVENTS IN CANCER PATIENTS TREATED WITH BEVACIZUMAB: A META-ANALYSIS

被引：0
|
作者：
Ranpura, Vishal [1 ]
Chuang, Jeff [1 ]
Wu, Shenhong [1 ]
机构：
[1] Stony Brook Univ Hosp, Stony Brook, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1155-276
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
    Ranpura, Vishal
    Hapani, Sanjaykumar
    Chuang, Jeff
    Wu, Shenhong
    ACTA ONCOLOGICA, 2010, 49 (03) : 287 - 297
  • [2] Risk of venous and arterial thromboembolic events in patients with metastatic breast cancer treated with bevacizumab: A meta-analysis
    Calvo, V.
    Ramirez, N.
    Saura, C.
    Vidal, M.
    Velasco, A.
    Llombart-Cussac, A.
    Cortes-Funes, H.
    Miles, D.
    Baselga, J.
    Cortes, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Increased Risk of Cerebrovascular Events in Patients with Cancer Treated with Bevacizumab: A Meta-Analysis
    Zuo, Pei-Yuan
    Chen, Xing-Lin
    Liu, Yu-Wei
    Xiao, Chang-Liang
    Liu, Cheng-Yun
    PLOS ONE, 2014, 9 (07):
  • [4] Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis
    Qi, Wei-Xiang
    Lin, Feng
    Sun, Yuan-Jue
    Tang, Li-Na
    Shen, Zan
    Yao, Yang
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (03) : 338 - 347
  • [5] Risk of Serious Neutropenic Events in Cancer Patients Treated with Bevacizumab: A Meta-analysis
    Zhou, Fan
    Shao, Jiang-Hua
    Wu, Lin-Quan
    Yin, Xiang-Bao
    Yu, Xin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (04) : 2453 - 2459
  • [6] RISK OF FATAL ADVERSE EVENTS WITH BEVACIZUMAB IN LUNG CANCER PATIENTS TREATED WITH CHEMOTHERAPY: A META-ANALYSIS
    Ranpura, V.
    Hapani, S.
    Wu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S94 - S94
  • [7] Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
    Tebbutt, N. C.
    Murphy, F.
    Zannino, D.
    Wilson, K.
    Cummins, M. M.
    Abdi, E.
    Strickland, A. H.
    Lowenthal, R. M.
    Marx, G.
    Karapetis, C.
    Shannon, J.
    Goldstein, D.
    Nayagam, S. S.
    Blum, R.
    Chantrill, L.
    Simes, R. J.
    Price, T. J.
    ANNALS OF ONCOLOGY, 2011, 22 (08) : 1834 - 1838
  • [8] Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis
    Hapani, Sanjaykumar
    Sher, Amna
    Chu, David
    Wu, Shenhong
    ONCOLOGY, 2010, 79 (1-2) : 27 - 38
  • [9] Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis
    Hapani, Sanjaykumar
    Chu, David
    Wu, Shenhong
    LANCET ONCOLOGY, 2009, 10 (06): : 559 - 568
  • [10] Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
    Scappaticci, Frank A.
    Skillings, Jamey R.
    Holden, Scott N.
    Gerber, Hans-Peter
    Miller, Kathy
    Kabbinavar, Fairooz
    Bergsland, Emily
    Ngai, James
    Holmgren, Eric
    Wang, Jiuzhou
    Hurwitz, Herbert
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (16): : 1232 - 1239
12345